POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 25258/0105 .
Glentek 50mg Film coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Glentek 50 mg film-coated tablets
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet:
1. What Glentek 50 mg Film-coated Tablets is and what it is used for
2. What you need to know before you take Glentek 50 mg Film-coated Tablets
3. How to take Glentek 50 mg Film-coated Tablets
4. Possible side effects
5. How to store Glentek 50 mg Film-coated Tablets
6. Contents of the pack and other information
1. What Glentek 50 mg film-coated tablets is and what it is used for
What Glentek 50 mg Film-coated Tablets are
The active substance in Glentek is riluzole which acts on the nervous system.
What Glentek 50 mg Film-coated Tablets are used for
Glentek is used in patients with amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness, muscle waste and paralysis.
The destruction of nerve cells in motor neurone disease may be caused by too much glutamate (a chemical messenger) in the brain and spinal cord. Glentek stops the release of glutamate and this may help in preventing the nerve cells being damaged.
Please consult your doctor for more information about ALS and the reason why this medicine has been prescribed for you.
2. What you need to know before you take Glentek 50 mg film-coated tablets
Do not take Glentek 50 mg Film-coated Tablets
Warnings and precautions
Talk to your doctor before taking Glentek 50 mg film-coated tablets:
If any of the above applies to you, or if you are not sure, tell your doctor who will decide what to do.
Children and adolescents
If you are less than 18 years of age, the use of Glentek 50 mg film-coated tablets is not recommended because there is no information available in this population.
Other medicines and Glentek 50 mg film-coated tablets:
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Pregnancy, breast-feeding and fertility
You MUST NOT take Glentek if you are or think you may be pregnant, or if you are breast-feeding.
If you think you may be pregnant, or if you intend to breast-feed, ask your doctor for advice before taking Glentek.
Driving and using machines
You can drive or use any tools or machines, unless you feel dizzy or light headed after taking this medicine.
3. How to take Glentek 50 mg film-coated tablets
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one tablet, twice a day.
The tablets should be taken by mouth, every 12 hours, at the same time of the day each day (e.g. in the morning and evening).
If you take more Glentek 50 mg Film-coated Tablets than you should
If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately.
If you forget to take Glentek 50 mg Film-coated Tablets
If you forget to take your tablet, leave out that dose completely and take the next tablet at the usual time.
Do not take a double dose to make up for a forgotten tablet.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately
Other side effects
Very common side effects (may affect more than 1 in 10 people) of Glentek are:
Common side effects (may affect up to 1 in 10 people ) of Glentek are:
Uncommon side effects (may affect up to 1 in 100 people) of Glentek are:
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE GLENTEK 50 MG FILM-COATED TABLETS
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP:. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. FURTHER INFORMATION
What Glentek 50 mg Film-coated Tablets contains
The active substance is riluzole.
Each film-coated tablet contains 50 mg of riluzole.
The other ingredients are:
Core: Calcium hydrogen phosphate anhydrous, Cellulose microcrystalline, Croscarmellose sodium, Silica colloidal anhydrous, Magnesium stearate;
Coating: Hypromellose, Titanium Dioxide (E171), Macrogol-400.
What Glentek 50 mg Film-coated Tablets looks like and contents of the pack
Glentek 50 mg film-coated Tablets are supplied as:
White to off-white, capsule shaped, bevelled edged film-coated tablets, engraved with ‘381’ on one side and ‘G’ on other side.
Glentek 50 mg film-coated Tablets are available in PVC/PVDC aluminium blisters of 28, 56, 98 film-coated tablets.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
This leaflet was last revised in 04/2020